Get a Quote
quote
Get a Quote
×
Quote Request

ChIA-PET Sequencing Service (RUO)

ChIA-PET is a protein-enriched 3D genomics approach designed to detect protein-mediated chromatin interactions at genome scale, producing loop-level outputs you can interpret alongside binding enrichment.

If your goal is to move beyond "global architecture" and quantify protein-anchored interaction networks (with deliverables your bioinformatics team can reuse), this ChIA-PET sequencing service is built for evaluation-ready reporting: clear QC checkpoints, explicit acceptance criteria (metric types), and browser-compatible deliverables.

Submit Your Request Now

ChIA-PET sequencing workflow for protein-mediated chromatin interaction mapping (RUO).

What ChIA-PET measures (and when it's the right choice)

ChIA-PET (Chromatin Interaction Analysis by Paired-End Tag sequencing) combines protein enrichment with proximity ligation and paired-end sequencing to identify long-range chromatin interactions mediated by a target protein/mark, along with enriched binding regions.

ChIA-PET helps you ask "which distal loci are connected through a target?" rather than "which loci contact each other on average." That distinction matters when your downstream goal is mechanistic interpretation and prioritization.

ChIA-PET is a strong fit when your evaluation criteria include:

  • Protein-anchored loop discovery: Interactions tied to a target context.
  • A paired output: Enrichment support + interactions for interpretable anchors.
  • Clear acceptance criteria: QC metric types and standardized deliverables for team reuse.

A well-scoped ChIA-PET project typically yields: interaction calls (loop/cluster style outputs) plus enrichment-support results; browser-ready tracks for rapid locus review; and a structured summary for internal review and downstream integration.

ChIA-PET Sequencing Service (RUO) — at a glance

  • Best for: Mapping protein-mediated chromatin interactions when you need loop-level outputs anchored to a target (RUO).
  • What you get: Interaction calls (loops/clusters), enrichment-support results, browser-ready tracks, and a structured QC summary.
  • How we reduce risk: Feasibility gating on sample + antibody suitability, plus stepwise QC reporting by workflow stage.
  • How to choose: If you are comparing ChIA-PET with HiChIP or PLAC-seq, focus on deliverables, QC reporting, and interpretability for your use case.
  • Next step: Request a quote with your sample type and target description to receive a scoped deliverables checklist (RUO).

Primary use cases for ChIA-PET (by target protein)

ChIA-PET is target-dependent, so "applications" are best framed as the analysis outcomes you want—without assuming a specific target list.

Protein-anchored loops for regulatory wiring

Prioritize candidate connections for follow-up assays. By focusing on interactions tied to a specific protein, you can validate regulatory networks more precisely than with global methods.

Network comparison across conditions

Contrast interaction patterns between treatment/perturbation states using consistent calling. This is essential for understanding how chromatin architecture shifts in response to stimuli or disease states.

Interaction + enrichment interpretation

Interpret anchors using enrichment support rather than loop calls alone. This dual output reinforces the biological relevance of detected interactions.

How teams commonly use ChIA-PET outputs

Wet lab teams use loop/anchor outputs to design focused validation experiments. Bioinformatics teams integrate loop calls with other signals to prioritize loci. Project leads use structured summaries to decide whether to expand scope.

ChIA-PET vs HiChIP vs PLAC-seq (how to choose)

Most buyers comparing protein-anchored 3D methods are balancing interpretability (protein-anchored vs general contacts), workflow/assay constraints (especially antibody and sample suitability), and the deliverables that best match their downstream analysis.

Decision Factor Guidance
Unit of Interpretation Do you need loop/cluster deliverables that your team will treat as "candidate regulatory edges"?
QC Transparency If you cannot see stepwise QC (metric types, not marketing claims), you cannot separate "biology" from "process failure."
Deliverables Make sure the deliverables are defined as file formats + browser artifacts, not as vague "report."

Practical "fit" framing:

Sample & antibody requirements (the real feasibility gate)

ChIA-PET feasibility is gated by two variables: Sample suitability (chromatin handling and crosslinking constraints) and Antibody performance (enrichment specificity supports anchor interpretability).

What you provide

  • Sample type and handling notes (cells/nuclei/tissue; preservation approach).
  • Target description (protein/mark class and expected binding pattern).
  • Study design summary (conditions/groups; whether comparisons are required).

What we evaluate (feasibility checklist)

  • Whether your target concept aligns with protein-anchored interaction mapping.
  • Whether antibody information suggests enrichment feasibility (risk-scored).
  • Whether sample constraints elevate risk and which controls reduce uncertainty.

Why feasibility gating matters: The biggest avoidable failure mode is not "low signal," but "an experiment that technically runs yet cannot support confident interaction interpretation." Feasibility gating reduces that risk before cost accumulates.

Workflow (wet lab → sequencing → analysis)

A typical ChIA-PET workflow spans chromatin preparation → enrichment → proximity ligation → PET library construction → paired-end sequencing → analysis from reads to loop calls and QC summaries.

Wet-lab workflow

  • Chromatin preparation: Fragmentation suitable for enrichment.
  • Target enrichment: ChIP-based capture of the protein of interest.
  • Proximity ligation: PET-style library construction to capture spatial contacts.
  • Library QC: Sequencing checks before full depth.

Bioinformatics workflow

A robust ChIA-PET analysis pipeline typically includes:

  • Linker/adapter handling and valid PET identification.
  • Alignment and duplicate handling.
  • Enrichment-support calling (peak-like outputs).
  • Interaction calling (loop/cluster outputs) plus reporting conventions.

QC dashboard schematic for ChIA-PET sequencing service including mapping, duplicates, PET composition, and loop summary.

QC & acceptance criteria (what we report, how you interpret)

We report QC metric types aligned to the workflow stages so your team can evaluate usability for your intended analyses—without relying on vague quality language.

Typical QC categories (metric types)

  • Sequencing & alignment QC: Read pair counts, alignment summaries, mapping-quality distributions.
  • Library composition QC: Duplicate-related summaries, valid PET identification summaries.
  • Enrichment support QC: Enrichment calling summaries to support anchor interpretation.
  • Interaction calling QC: Loop/cluster call summaries and distance distribution summaries.

How to use QC to accept results

Your evaluation team should be able to answer:

  • Do alignments and valid PET identification support interaction calling?
  • Is enrichment support sufficient to interpret anchors?
  • Are outputs stable enough for the comparisons you plan to make?

Deliverables (files, plots, and what your team can reuse)

Deliverables are structured to support PI review (interpretation-ready summaries), bioinformatics reuse (standardized files), and team alignment.

Interaction outputs
Loop/cluster call tables (often BEDPE-like or equivalent tabular formats).

Enrichment support
Peak/enriched-region tables.

Browser-ready tracks
Track files appropriate for genome browsers plus configuration notes.

QC summary pack
Stepwise QC metric-type report aligned to workflow stages.

Visualization pack
Locus-level loop visualization artifacts (arc-style plots or equivalent) and snapshot-ready figures.

ChIA-PET sequencing deliverables mockup with interaction cluster table, loop visualization, and genome browser tracks.

Case study (peer-reviewed, reusable figure)

This case study illustrates what an interaction deliverable can look like in peer-reviewed literature, using a figure that is explicitly licensed for reuse with attribution.

A foundational Genome Biology paper describing ChIA-PET processing and visualization includes example browser views of interaction clusters.

The paper shows a table-style interaction cluster view, conceptually similar to the interaction tables many evaluation teams expect for review and downstream analysis.

Figure 9: "Screen shot of interaction cluster table view in ChIA-PET browser." This figure is a useful proxy for evaluation-ready deliverables: a filterable table-style view of interaction clusters that supports inspection and triage.

When requesting a quote, specify whether your team prefers a table-first interaction deliverable (easy to filter and integrate), and browser-ready tracks to support locus review and anchor inspection.

Frequently Asked Questions

References

  1. Li G, Fullwood MJ, Xu H, et al. ChIA-PET tool for comprehensive chromatin interaction analysis with paired-end tag sequencing. Genome Biology (2010).
  2. Li G, Chen Y, Snyder MP, Zhang MQ. ChIA-PET2: a versatile pipeline for ChIA-PET data analysis. Nucleic Acids Research (2017).
  3. ENCODE Project. ChIA-PET protocol for ENCODE4 (PDF).
  4. Chromatin Interaction Analysis with Paired-End Tag (ChIA-PET) sequencing technology and application. BMC Genomics (2014).

Compliance & Trust:

  • Research Use Only (RUO): This ChIA-PET sequencing service is provided for research purposes and is not intended for diagnostic use.
  • Data handling: Secure delivery options can be supported for sequencing data and analysis outputs, with project-scoped access controls for data transfer and storage.
  • Scope clarity: Deliverables, file formats, and QC report sections are defined in writing at project kickoff to support transparent acceptance.
Leading Your Research Forward

Enhancing your vision research capabilities.

High-confidence 3D genomics services for chromatin interaction analysis and regulatory insight.

Quick Links
Contact Us
Copyright © CD Genomics. All Rights Reserved.
Top